The 10 new flu-related deaths in children bring the season's total to 226, the most since 2009-10.
Plaque growth can lead to a higher risk of heart attack, stroke, and other life-threatening cardiovascular events for as long as 1 year.
Post-exertional malaise, or exercise intolerance, was seen in 36% of those with long COVID.
Get weekly COVD-19 updates in your inbox.
Catch the latest episode!
Top COVID FAQs
By CIDRAP & other experts
Read all 7 reports
VRBPAC experts approved the booster recommendation by a 17-to-2 vote.
A new study from researchers at Boston University (BU) shows that, for all but 17% of healthy, vaccinated young adults, the infectious period for COVID-19 from the Delta and Omicron variants was 5 days. The study was recently published in Clinical Infectious Diseases.
The incidence dropped by one-fifth for both mRNA vaccines when dose spacing was longer.
The Journal of Infectious Diseases has published studies demonstrating lower COVID-19 incidence—but a higher risk of severe disease—in people with Down syndrome (DS), and a lower COVID vaccine immune response.
An additional 600,000 lives might have been saved if global vaccination goals had been met.
A study yesterday in JAMA Internal Medicine shows that a fourth Pfizer COVID-19 vaccine dose provided 64% to 67% protection against hospitalization and 72% protection against death in nursing home residents, but only 34% protection against infection during an Omicron-dominated period.
The absolute risk appears to be only slightly higher than in uninfected peers.
Maternal COVID vaccination during pregnancy provides 52% protection against COVID-19 hospitalization in infants but only 38% protection against Omicron hospitalization, according to a study yesterday in the New England Journal of Medicine.
Protection against an intensive care unit (ICU) stay, however, was 70%.
Only 0.74% of patients visited an emergency department and only 0.11% a hospital.
The vaccine produces a strong immune response against the BA.4 and BA.5 Omicron subvariants.
